These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
|
|
Preliminary Proxy Statement
|
|
|||
|
o
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
||||
|
ý
|
|
Definitive Proxy Statement
|
|
|||
|
o
|
|
Definitive Additional Materials
|
|
|||
|
o
|
|
Soliciting Material Pursuant to §240.14a-12
|
|
|||
|
x
|
|
No fee required.
|
|
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
5)
|
Total fee paid:
|
|
o
|
|
Fee paid previously with preliminary materials.
|
|
o
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
1)
|
Amount Previously Paid:
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
|
3)
|
Filing Party:
|
|
|
4)
|
Date Filed:
|
|
Dan Rosensweig
President and Chief Executive Officer
|
|
Robert Chesnut
Senior Vice President, General Counsel and Secretary
|
|
|
|
|
|
|
|
|
•
|
vote in person - we will provide a ballot to stockholders who attend the meeting and wish to vote in person;
|
|
•
|
vote via telephone or via the Internet - in order to do so, please follow the instructions shown on your Notice of Internet Availability or proxy card; or
|
|
•
|
vote by mail - if you request or receive a paper proxy card and voting instructions by mail, simply complete, sign and date the enclosed proxy card and return it before the meeting in the envelope provided.
|
|
•
|
delivering to the Corporate Secretary of Chegg (by any means, including facsimile) a written notice stating that the proxy is revoked;
|
|
•
|
signing and delivering a proxy bearing a later date;
|
|
•
|
voting again by telephone or through the Internet; or
|
|
•
|
attending and voting at the meeting (although attendance at the meeting will not, by itself, revoke a proxy).
|
|
•
|
view our proxy materials for the meeting through the Internet; and
|
|
•
|
instruct us to send our future proxy materials to you electronically by email.
|
|
•
|
selects a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;
|
|
•
|
helps to ensure the independence and performance of and oversees our company’s relationship with the independent registered public accounting firm;
|
|
•
|
discusses the scope and results of the audit with the independent registered public accounting firm, and reviews, with management and the independent registered public accounting firm, our interim and year-end operating results;
|
|
•
|
develops procedures for employees to submit concerns anonymously about questionable accounting or audit matters;
|
|
•
|
considers the adequacy of our internal accounting controls and audit procedures; and
|
|
•
|
approves or, as required, pre-approves all audit and non-audit services not prohibited by law to be performed by the independent registered public accounting firm.
|
|
•
|
reviews and determines the compensation of our executive officers and recommends to our board of directors the compensation for our directors;
|
|
•
|
administers our stock and equity incentive plans;
|
|
•
|
reviews and approves and makes recommendations to our board of directors regarding incentive compensation and equity plans; and
|
|
•
|
establishes and reviews general strategies relating to compensation and benefits of our employees.
|
|
•
|
identifies, evaluates and recommends nominees to our board of directors and committees of our board of directors;
|
|
•
|
conducts searches for appropriate directors;
|
|
•
|
evaluates the performance of our board of directors and of individual directors;
|
|
•
|
considers and makes recommendations to the board of directors regarding the composition of the board and its committees;
|
|
•
|
reviews developments in corporate governance practices;
|
|
•
|
evaluates the adequacy of our corporate governance practices and reporting; and
|
|
•
|
makes recommendations to our board of directors concerning corporate governance matters.
|
|
Name of Director/Nominee
|
Age
|
Principal Occupation
|
Director Since
|
|
Marne Levine
(1)(2)
|
44
|
Chief Operating Officer, Instagram
|
May 2013
|
|
Richard Sarnoff
(3)
|
56
|
Managing Director and Head of the Media & Communications industry group, Kohlberg Kravis Roberts & Co.
|
August 2012
|
|
(1)
|
Member of the nominating and corporate governance committee
|
|
(2)
|
Member of the compensation committee
|
|
(3)
|
Member of the audit committee
|
|
Name of Director
|
Age
|
Principal Occupation
|
Director Since
|
|
Class III Directors -
Terms Expiring 2016:
|
|
|
|
|
Jeffrey Housenbold
(1)
|
45
|
President and Chief Executive Officer of Shutterfly
|
May 2013
|
|
John York
(2)(3)
|
34
|
Chief Executive Officer of the San Francisco 49ers
|
June 2013
|
|
|
|
|
|
|
Class I Directors -
Terms Expiring 2017:
|
|
|
|
|
Barry McCarthy
(2)
|
61
|
Entrepreneur
|
March 2010
|
|
Dan Rosensweig
|
53
|
President and Chief Executive Officer of Chegg
|
March 2010
|
|
Ted Schlein
(1)(3)
|
51
|
General Partner of Kleiner Perkins Caufield & Byers
|
December 2008
|
|
(1)
|
Member of the compensation committee
|
|
(2)
|
Member of the audit committee
|
|
(3)
|
Member of the nominating and corporate governance committee
|
|
•
|
an annual cash retainer for serving on the board of directors of $40,000;
|
|
•
|
an annual cash retainer for serving in a non-chair position on the audit committee of $10,000, on the compensation committee of $10,000 and on the nominating and corporate governance committee of $5,000; and
|
|
•
|
an annual cash retainer for serving as the chair of the audit committee of $20,000, for serving as the chair of the compensation committee of $20,000 and for serving as the chair of the nominating and corporate governance committee of $10,000.
|
|
Name
|
|
Fees Earned
or Paid in Cash ($) |
|
Option
Awards
($)
(1)
|
|
Total
($)
|
|||
|
Jeffrey Housenbold
|
|
50,000
|
|
|
189,818
|
|
|
239,818
|
|
|
Marne Levine
|
|
60,000
|
|
|
189,818
|
|
|
249,818
|
|
|
Barry McCarthy
|
|
60,000
|
|
|
189,818
|
|
|
249,818
|
|
|
Richard Sarnoff
|
|
50,000
|
|
|
189,818
|
|
|
239,818
|
|
|
Ted Schlein
|
|
65,000
|
|
|
189,818
|
|
|
254,818
|
|
|
John York
|
|
55,000
|
|
|
189,818
|
|
|
244,818
|
|
|
(1)
|
Amounts shown in this column do not reflect dollar amounts actually received by non-employee directors. Instead these amounts reflect the aggregate grant date fair value calculated in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification Topic 718,
Compensation-Stock Compensation
, (formerly SFAS 123R), or ASC 718, for awards granted during 2014. For purposes of determining the number of shares of common stock subject to the stock option award, an expected term of one-year, the vesting period, was used, assuming an aggregate grant date fair value of $150,000. The aggregate grant date fair value shown in this column assumes an expected term of 5.5 years, which is the term used for accounting purposes. For information on other valuation assumptions with respect to stock option awards, refer to note 14 of the notes to consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014. There can be no assurance that this grant date fair value will ever be realized by the non-employee director.
|
|
|
|
|
|
Name
|
Option Awards
|
|
|
Jeffrey Housenbold
|
116,917
|
|
|
Marne Levine
|
116,917
|
|
|
Barry McCarthy
|
198,323
|
|
|
Richard Sarnoff
|
202,222
|
|
|
Ted Schlein
|
95,557
|
|
|
John York
|
116,917
|
|
|
|
|
|
|
|
||||
|
Fees Billed to Chegg
|
|
Fiscal Year 2014
|
|
Fiscal Year 2013
|
||||
|
Audit fees
(1)
|
|
$
|
1,666,489
|
|
|
$
|
2,326,986
|
|
|
Audit related fees
(2)
|
|
87,100
|
|
|
—
|
|
||
|
Tax fees
(3)
|
|
26,319
|
|
|
—
|
|
||
|
All other fees
|
|
—
|
|
|
—
|
|
||
|
Total fees
|
|
$
|
1,779,908
|
|
|
$
|
2,326,986
|
|
|
(1)
|
“Audit fees”
include fees for professional services rendered in connection with the audit of our annual financial statements and review of our quarterly financial statements. In addition, this category also includes fees for services that were incurred in connection with our initial public offering completed in November 2013, and other statutory and regulatory filings or engagements.
|
|
(2)
|
“Audit related fees”
include fees for professional services rendered in connection with acquisition and other advisory services.
|
|
(3)
|
“Tax fees”
include fees in connection with tax compliance and tax advisory and consulting services.
|
|
•
|
each stockholder known by us to be the beneficial owner of more than 5% of our common stock;
|
|
•
|
each of our directors or director nominees;
|
|
•
|
each of our named executive officers; and
|
|
•
|
all of our directors and executive officers as a group.
|
|
Name of Beneficial Owner
|
|
Number of Shares Beneficially Owned
|
|
Percentage
Owned
|
||
|
Named Executive Officers and Directors:
|
|
|
|
|
||
|
Dan Rosensweig
(1)
|
|
2,823,681
|
|
|
3.2
|
%
|
|
Andy Brown
(2)
|
|
819,827
|
|
|
*
|
|
|
Chuck Geiger
(3)
|
|
979,813
|
|
|
1.1
|
%
|
|
Jeffrey Housenbold§
|
|
96,546
|
|
|
*
|
|
|
Barry McCarthy
(4)
|
|
312,111
|
|
|
*
|
|
|
Marne Levine§
|
|
94,695
|
|
|
*
|
|
|
Richard Sarnoff§
|
|
175,865
|
|
|
*
|
|
|
Ted Schlein
(5)
|
|
8,448,039
|
|
|
9.8
|
%
|
|
John York
(6)
|
|
96,695
|
|
|
*
|
|
|
All executive officers and directors as a group (14 persons)
(7)
|
|
16,088,464
|
|
|
18.6
|
%
|
|
5% Stockholders:
|
|
|
|
|
|
|
|
Entities Affiliated with Insight Venture Partners
(8)
|
|
8,677,391
|
|
|
10.1
|
%
|
|
KPCB Holdings, as nominee
(9)
|
|
8,355,135
|
|
|
9.7
|
%
|
|
PAR Investment Partners, L.P.
(10)
|
|
7,500,000
|
|
|
8.7
|
%
|
|
Entities Affiliated with Gabriel Ventures
(11)
|
|
7,358,364
|
|
|
8.6
|
%
|
|
Entities Associated with Foundation Capital
(12)
|
|
4,670,819
|
|
|
5.4
|
%
|
|
*
|
Represents beneficial ownership of less than 1% of our outstanding shares of common stock.
|
|
§
|
Shares shown for this individual represent shares subject to stock options that are exercisable within 60 days of
April 10, 2015
.
|
|
(2)
|
Consists of (a) 131,062 shares held by Mr. Brown, (b) 51,061 shares held by The Andy and Pam Brown Family Trust, of which Mr. Brown is a Co-Trustee, (c) 3,333 shares held by Chelsea Brown, Mr. Brown’s daughter, (d) 3,333 shares held by Kevin Brown, Mr. Brown’s son, (e) 629,914 shares subject to stock options held by Mr. Brown that are exercisable within 60 days of April 10, 2015, and (f) 1,124 RSUs which are subject to vesting conditions expected to occur within 60 days of April 10, 2015.
|
|
(3)
|
Consists of (a) 74,090 shares held by Mr. Geiger, (b) 905,387 shares subject to stock options held by Mr. Geiger that are exercisable within 60 days of April 10, 2015, and (c) 336 RSUs which are subject to vesting conditions expected to occur within 60 days of April 10, 2015.
|
|
(4)
|
Consists of (a) 65,609 shares held by Mr. McCarthy, (b) 53,499 shares held by Rivers Cross Trust, (c) 17,333 shares held by Peter Dudley McCarthy Trust, and (d) 175,670 shares subject to stock options held by Mr. McCarthy that are exercisable within 60 days of April 10, 2015.
|
|
(5)
|
Consists of (a) 20,000 shares held by the Schlein Family Trust Dtd 4/20/99, (b) 72,904 shares subject to stock options held by Mr. Schlein that are exercisable within 60 days of April 10, 2015, and (b) 8,355,135 shares owned by Kleiner Perkins Caufield & Byers XIII, LLC (KPCB XIII). All shares are held for convenience in the name of “KPCB Holdings, Inc. as nominee,” for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The managing member of KPCB XIII is KPCB XIII Associates, LLC (KPCB XIII Associates). Brook H. Byers, L. John Doerr, Joseph Lacob, Raymond J. Lane and Ted Schlein, a member of our board of directors, are the managing directors of KPCB XIII Associates and exercise shared voting and investment power over the shares directly held by KPCB XIII. The principal business address for all entities and individuals affiliated with Kleiner Perkins Caufield & Byers is 2750 Sand Hill Road, Menlo Park, CA 94025.
|
|
(6)
|
Consists of (a) 2,000 shares held by Mr. York, (b) 94,695 shares subject to stock options held by Mr. York that are exercisable within 60 days of April 10, 2015.
|
|
(7)
|
Consists of (a) 9,706,816 shares, (b) 6,375,680 shares subject to stock options that are exercisable within 60 days of April 10, 2015, and (c) 5,968 RSUs which are subject to vesting conditions expected to occur within 60 days of April 10, 2015, each of which are held by our directors and officers as a group.
|
|
(8)
|
Consists of (a) 1,986,489 shares held by Insight Venture Partners (Cayman) VI, L.P., (b) 367,462 shares held by Insight Venture Partners VI (Co-Investors), L.P., and (c) 6,323,440 shares held by Insight Venture Partners VI, L.P. Insight Holdings Group, LLC (Holdings) is the general partner of Insight Venture Associates VI, L.P., which is the general partner of each of Insight Venture Partners VI, L.P., Insight Venture Partners (Cayman) VI, L.P. and Insight Venture Partners VI (Co-Investors), L.P. Each of Jeffrey Horing, Deven Parekh and Peter Sobiloff is a member of the board of managers of Holdings and share voting and investment power over the shares. Each of Messrs. Horing, Parekh and Sobiloff disclaims beneficial ownership of the shares except to the extent of his pecuniary interest in these entities. The principal business address for all entities and individuals affiliated with Insight Venture Partners is 1114 Avenue of the Americas, 36
th
Floor, New York, NY 10036.
|
|
(9)
|
Consists of 7,792,000 shares owned by KPCB XIII and 563,135 shares beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers. All shares are held for convenience in the name of “KPCB Holdings, Inc. as nominee,” for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The managing member of KPCB XIII is KPCB XIII Associates. Brook H. Byers, L. John Doerr, Joseph Lacob, Raymond J. Lane and Ted Schlein, a member of our board of directors, are the managing directors of KPCB XIII Associates and exercise shared voting and investment power over the shares directly held by KPCB XIII. The principal business address for all entities and individuals affiliated with Kleiner Perkins Caufield & Byers is 2750 Sand Hill Road, Menlo Park, CA 94025.
|
|
(10)
|
The sole general partner of PAR Investment Partners, L.P. is PAR Group, L.P. The sole general partner of PAR Group L.P., is PAR Capital Management, Inc. Each of PAR Group, L.P. and PAR Capital Management, Inc. may be deemed to be the beneficial owner of all 7,500,000 shares held directly by PAR Investment Partners, L.P.
|
|
(11)
|
Consists of (a) 21,421 shares held by Gabriel Legacy Fund II, L.P. and (b) 7,336,943 shares held by Gabriel Venture Partners II, L.P. Gabriel Investment Partners II, L.P. (Gabriel Investment) serves as the General Partner of such entities. Scott Chou and Frederick Bolander are the managing partners of Gabriel Investment and share voting and investment power over the shares. The principal business address for all entities affiliated with Gabriel Venture Partners is 999 Baker Way, Suite 400, San Mateo, CA 94404.
|
|
Name
|
|
Age
|
|
Position(s)
|
|
Dan Rosensweig
|
|
53
|
|
President, Chief Executive Officer and Chairman
|
|
Andrew Brown
|
|
55
|
|
Chief Financial Officer
|
|
Robert Chesnut
|
|
55
|
|
Senior Vice President and General Counsel
|
|
Anne Dwane
|
|
44
|
|
Chief Business Officer
|
|
Chuck Geiger
|
|
48
|
|
Chief Technology Officer
|
|
Esther Lem
|
|
59
|
|
Chief Marketing Officer
|
|
Michael Osier
|
|
52
|
|
Chief Information Officer
|
|
Nathan Schultz
|
|
37
|
|
Chief Learning Officer
|
|
Name and Principal Position
|
Year
|
Salary ($)
(1)
|
Stock
Awards ($)
(2)
|
Option
Awards ($)
(3)
|
All other Compensation($)
(4)
|
Total ($)
|
||||||
|
Dan Rosensweig
|
2014
|
700,000
|
|
4,289,992
|
|
—
|
|
—
|
|
$
|
4,989,992
|
|
|
President and Chief Executive Officer
|
2013
|
603,077
|
|
1,898,275
|
|
6,438,846
|
|
29,614
|
|
$
|
8,969,812
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Andrew Brown
|
2014
|
410,000
|
|
1,539,991
|
|
—
|
|
5,750
|
|
$
|
1,955,741
|
|
|
Chief Financial Officer
|
2013
|
389,356
|
|
437,288
|
|
2,268,718
|
|
2,000
|
|
$
|
3,097,362
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Chuck Geiger
|
2014
|
410,267
|
|
1,209,990
|
|
—
|
|
4,281
|
|
$
|
1,624,538
|
|
|
Chief Technology Officer
|
2013
|
381,000
|
|
739,325
|
|
2,246,846
|
|
2,000
|
|
$
|
3,369,171
|
|
|
(1)
|
The annual base salary for
Messrs. Rosensweig, Brown and Geiger,
e
ffective as of July 1, 2012, was $580,000, $381,000 and $381,000, respectively. Effective November 13, 2013, Messrs. Rosensweig and Brown’s annual base salary was increased to $700,000 and $410,000, respectively. Effective May 12, 2014, Mr.
Geiger's annual base salary was increased to $426,720.
|
|
(2)
|
The amounts reported in this column represent the aggregate grant date fair value of restricted stock unit awards granted under our 2013 Equity Incentive Plan, as computed in accordance with FASB ASC Topic 718. The grant date fair value was determined using the closing share price of our common stock on the date of grant. For 2014, the amounts include performance-based stock units, or PSUs, valued at the grant date based upon the probable outcome of the performance conditions. The aggregate grant date fair values of the PSUs were $2,339,997, $839,997 and $659,996 for Messrs. Rosensweig, Brown and Geiger, respectively. The maximum potential value of the PSUs (assuming the highest level of performance achievement) for Messrs. Rosensweig, Brown and Geiger would be $2,925,002, $1,049,998, and $825,000, respectively.
|
|
(3)
|
The amounts reported in this column represent the aggregate grant date fair value of stock option awards granted under our 2005 Stock Incentive Plan, with respect to awards granted to our named executive officers in 2013 and under our 2013 Equity Incentive Plan, with respect to awards granted to our named executive officers in 2014, as computed in accordance with FASB ASC Topic 718. For information on the valuation assumptions with respect to stock option awards, refer to Note 14 of the notes to consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014. Note that the amounts reported in this column reflect the accounting cost for these equity awards and do not correspond to the actual economic value that may be received by our named executive officers from the equity awards.
|
|
(4)
|
Represents our contributions to the account under our 401(k) plan with respect to each of Messrs. Brown and Geiger.
|
|
|
|
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||||
|
|
|
Grant
Date
(1)
|
|
Number of Securities
Underlying Unexercised
Options
|
|
Exercise
Price
($)
|
|
Expiration
Date
|
|
Number of
Shares that
Have Not
Vested
(#)
|
|
Market
Value of
Shares that
Have Not
Vested ($)
(2)
|
|||||||
|
Name
|
|
|
Exercisable (#)
|
|
Unexercisable
(#)
|
|
|||||||||||||
|
Dan Rosensweig
|
|
3/17/2011
(3)
|
|
1,000,000
|
|
|
—
|
|
|
7.88
|
|
|
2/3/2020
|
|
|
|
|
||
|
|
|
5/4/2011
(4)
|
|
215,277
|
|
|
118,056
|
|
|
7.88
|
|
|
5/3/2021
|
|
|
|
|
||
|
|
|
11/7/2012
(5)
|
|
373,747
|
|
|
343,849
|
|
|
6.92
|
|
|
11/6/2022
|
|
|
|
|
||
|
|
|
11/12/2013
(6)
|
|
257,490
|
|
|
56,917
|
|
|
12.50
|
|
|
11/11/2023
|
|
|
|
|
||
|
|
|
11/12/2013
(7)
|
|
240,740
|
|
|
425,926
|
|
|
12.50
|
|
|
11/11/2023
|
|
|
|
|
||
|
|
|
11/12/2013
(8)
|
|
|
|
|
|
|
|
|
|
27,521
|
|
|
190,170
|
|
|||
|
|
|
2/26/2014
(9)
|
|
|
|
|
|
|
|
|
|
306,604
|
|
|
2,118,634
|
|
|||
|
|
|
2/26/2014
(10)
|
|
|
|
|
|
|
|
|
|
306,603
|
|
|
2,118,627
|
|
|||
|
Andy Brown
|
|
11/2/2011
(11)
|
|
344,047
|
|
|
97,223
|
|
|
7.88
|
|
|
11/1/2021
|
|
|
|
|
||
|
|
|
11/7/2012
(5)
|
|
20,833
|
|
|
19,167
|
|
|
6.92
|
|
|
11/6/2022
|
|
|
|
|
||
|
|
|
11/12/2013
(12)
|
|
62,178
|
|
|
14,910
|
|
|
12.50
|
|
|
11/11/2023
|
|
|
|
|
||
|
|
|
11/12/2013
(7)
|
|
96,295
|
|
|
170,371
|
|
|
12.50
|
|
|
11/11/2023
|
|
|
|
|
||
|
|
|
11/12/2013
(13)
|
|
|
|
|
|
|
|
|
|
6,757
|
|
|
46,691
|
|
|||
|
|
|
2/26/2014
(9)
|
|
|
|
|
|
|
|
|
|
110,063
|
|
|
760,535
|
|
|||
|
|
|
2/26/2014
(10)
|
|
|
|
|
|
|
|
|
|
110,062
|
|
|
760,528
|
|
|||
|
Chuck Geiger
|
|
7/22/2009
|
|
635,729
|
|
|
—
|
|
|
1.88
|
|
|
7/21/2019
|
|
|
|
|
||
|
|
|
11/7/2012
(5)
|
|
52,082
|
|
|
47,918
|
|
|
6.92
|
|
|
11/6/2022
|
|
|
|
|
||
|
|
|
11/12/2013
(14)
|
|
70,674
|
|
|
4,917
|
|
|
12.50
|
|
|
11/11/2023
|
|
|
|
|
||
|
|
|
11/12/2013
(7)
|
|
96,295
|
|
|
170,371
|
|
|
12.50
|
|
|
11/11/2023
|
|
|
|
|
||
|
|
|
11/12/2013
(15)
|
|
|
|
|
|
|
|
|
|
3,863
|
|
|
26,963
|
|
|||
|
|
|
2/26/2014
(9)
|
|
|
|
|
|
|
|
|
|
86,478
|
|
|
597,563
|
|
|||
|
|
|
2/26/2014
(10)
|
|
|
|
|
|
|
|
|
|
86,477
|
|
|
597,556
|
|
|||
|
(1)
|
All of the outstanding equity awards granted prior to November 12, 2013 were granted under our 2005 Stock Incentive Plan. The outstanding equity awards granted on or after November 12, 2013 were granted under our 2013 Equity Incentive Plan.
|
|
(2)
|
The market price for our common stock is based on the closing price per share of our common stock as listed on the NYSE on
December 31, 2014
of
$6.91
.
|
|
(3)
|
25% of the option vested on January 15, 2011 and 1/48th vests monthly thereafter, subject to acceleration as described in “-Termination or Change in Control Arrangements” below. Includes 68,251 shares subject to stock options transferred as a gift to Daniel Lee Rosensweig and Linda Rosensweig Co-Trustees of the Rosensweig 2012 Irrevocable Children’s Trust u/a/d 11/6/2012 on November 8, 2013.
|
|
(4)
|
25% of the option vested on May 4, 2013 and 1/36th vests monthly thereafter, subject to acceleration as described in “-Termination or Change in Control Arrangements” below.
|
|
(5)
|
1/48th of the option vests monthly beginning on the grant date, subject to acceleration as described in “-Termination or Change in Control Arrangements” below.
|
|
(6)
|
On the grant date, 153,079 shares subject to the option were vested and immediately exercisable. Over the first 12-month period following the grant date, a total of 101,712 shares subject to the option will vest in equal monthly installments. Over the second 12-month period following the grant date, a total of 32,388 subject to the option will vest in equal monthly installments. Over the third 12-month period following the grant date, a total of 27,228 shares subject to the option will vest in equal monthly installments. The vesting is subject to acceleration as described in“-Termination or Change in Control Arrangements” below.
|
|
(7)
|
33% of the option vests on November 12, 2014 and 1/24
th
vests monthly thereafter, subject to acceleration as described in “-Termination or Change in Control Arrangements” below.
|
|
(8)
|
Over the first 12-month period following the grant date, a total of 49,116 shares subject to the restricted stock units, or RSUs, will vest in equal monthly installments. Over the second 12-month period following the grant date, a total of 15,636 shares subject to the RSUs will vest in equal monthly installments. Over the third 12-month period following the grant date, a total of 13,188 shares subject to the RSUs will vest in equal monthly installments. The vesting is subject to acceleration as described in“-Termination or Change in Control Arrangements” below.
|
|
(9)
|
Upon the achievement by December 31, 2014 of company performance metrics measurements approved by the Compensation Committee of the Board of Directors, the RSUs allocated (if any) to each performance metric shall vest as to 1/3 no later than March 15, 2015; 1/3 on the one year anniversary of the determined vesting date; and 1/3 on the two year anniversary of the determined vesting date, subject to the Reporting Person's continued service up to and through the applicable vesting dates.
|
|
(10)
|
33% of the shares will vest annually. Vest base date February 26, 2014. The vesting is subject to acceleration as described in“-Termination or Change in Control Arrangements” below.
|
|
(11)
|
25% of the option vested on October 3, 2012 and 1/48th vests monthly thereafter, subject to acceleration as described in “-Termination or Change in Control Arrangements” below.
|
|
(12)
|
On the grant date, 32,152 shares subject to the option were vested and immediately exercisable. Over the first 12-month period following the grant date, a total of 28,788 shares subject to the option will vest in equal monthly installments. Over the second 12-month period following the grant date, a total of 14,856 shares subject to the option will vest in equal monthly installments. Over the third 12-month period following the grant date, a total of 1,292 shares subject to the option will vest in equal monthly installments. The vesting is subject to acceleration as described in“-Termination or Change in Control Arrangements” below.
|
|
(13)
|
Over the first 12-month period following the grant date, a total of 13,068 shares subject to the RSUs will vest in equal monthly installments. Over the second 12-month period following the grant date, a total of 6,744 shares subject to the RSUs will vest in equal monthly installments. Over the third 12-month period following the grant date, a total of 575 shares subject to the RSUs will vest in equal monthly installments. The vesting is subject to acceleration as described in“-Termination or Change in Control Arrangements” below.
|
|
(15)
|
Over the first 12-month period following the grant date, a total of 1,992 shares subject to the RSUs will vest in equal monthly installments. Over the second 12-month period following the grant date, a total of 2,016 shares subject to the RSUs will vest in equal monthly installments. Over the third 12-month period following the grant date, a total of 2,015 shares subject to the RSUs will vest in equal monthly installments. The vesting subject to acceleration as described in“-Termination or Change in Control Arrangements” below.
|
|
Plan category
|
|
Number of securities to be
issued upon exercise
of outstanding options,
warrants and rights
|
|
Weighted-average exercise price of
outstanding options,
warrants and rights
|
|
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a))
|
|
|
|
(a)
|
|
(b)
|
|
(c)
|
|
Equity compensation plans approved by security holders
|
|
23,888,106
(1)
|
|
$8.55
(2)
|
|
12,964,564
(3)
|
|
Equity compensation plans not approved by security holders
(4)
|
|
N/A—
|
|
N/A—
|
|
N/A—
|
|
(1)
|
Excludes purchase rights accruing under the 2013 ESPP and includes 8,988,038 shares subject to outstanding restricted stock units.
|
|
(2)
|
The weighted average exercise price relates solely to outstanding stock option shares since shares subject to restricted stock units have no exercise price.
|
|
(3)
|
Consists of 8,488,099 shares available for issuance under the 2013 Plan and 4,476,465 shares available for issuance under the 2013 ESPP.
The number of shares reserved for issuance under the 2013 Plan will increase automatically on the first day of January of each of the first ten calendar years during the term of the plan by a number of shares of common stock equal to the lesser of (i) 5% of the total outstanding shares our common stock as of the immediately preceding December 31st or (ii) a number of shares determined by our board of directors.
The number of shares reserved for issuance under our 2013 ESPP will increase automatically on January 1st of each of the first ten calendar years following the first offering date by the number of shares equal to the lesser of (i) 1% of the total outstanding shares of our common stock as of the immediately preceding December 31st (rounded to the nearest whole share) or (ii) a number of shares determined by our board of directors.
Pursuant to the terms of our 2013 Plan and 2013 ESPP, an additional 4,200,402 shares and 840,080 shares were added to the number of shares reserved for issuance under the each plan, respectively, effective January 1, 2015.
|
|
(4)
|
Excludes information for options and other equity awards assumed by us in connection with mergers and acquisitions and warrants issued by us in connection with financing transactions. As of December 31, 2014, a total of 62,031 shares of our common stock were issuable upon exercise of outstanding options assumed and 995,549 shares of our common stock were issuable upon exercise of outstanding warrants issued in connection with financing transactions. The weighted average exercise price of those outstanding options and warrants was $4.82 per share and $5.70 per share, respectively. No additional equity awards may be granted under any equity compensation plans or arrangements assumed by us in connection with mergers and acquisitions.
|
|
•
|
we have been or are to be a participant;
|
|
•
|
the amount involved exceeded or exceeds $120,000; and
|
|
•
|
any of our directors, executive officers or holders of more than 5% of our capital stock, or any immediate family member of or person sharing the household with any of these individuals, had or will have a direct or indirect material interest.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|